Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | Director | May 07, 2026 | May 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 17,700 |
Reported balance
After 2026-05-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 17,700 · Balance 17,700 F1: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. F2: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. The reporting person elected to defer receipt of the shares underlying the RSUs. In accordance with her deferral election, vested shares will be delivered to the reporting person in one lump sum, in the calendar year next following the calendar year in which the reporting person's termination of service on the Board of Directors occurs (unless the reporting person elected a later calendar year). |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock.
F2: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. The reporting person elected to defer receipt of the shares underlying the RSUs. In accordance with her deferral election, vested shares will be delivered to the reporting person in one lump sum, in the calendar year next following the calendar year in which the reporting person's termination of service on the Board of Directors occurs (unless the reporting person elected a later calendar year).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2026 Filed May 11, 2026 20:39 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 17,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001857606-26-000001 · wk-form4_1778531995.xml · derivative · entry 1 Clay Shaundra · CIK 0001857606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,700 Underlying: Common Stock · 17,700 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. F2 · derivative.exercise_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. The reporting person elected to defer receipt of the shares underlying the RSUs. In accordance with her deferral election, vested shares will be delivered to the reporting person in one lump sum, in the calendar year next following the calendar year in which the reporting person's termination of service on the Board of Directors occurs (unless the reporting person elected a later calendar year). F2 · derivative.expiration_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. The reporting person elected to defer receipt of the shares underlying the RSUs. In accordance with her deferral election, vested shares will be delivered to the reporting person in one lump sum, in the calendar year next following the calendar year in which the reporting person's termination of service on the Board of Directors occurs (unless the reporting person elected a later calendar year). Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:20 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 19,592 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000047 · wk-form4_1747167624.xml · nonDerivative · entry 1 Clay Shaundra · CIK 0001857606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,515 Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:57 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 8,696 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000070 · wk-form4_1715633830.xml · nonDerivative · entry 1 Clay Shaundra · CIK 0001857606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,923 Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 4,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029808 · doc4.xml · nonDerivative · entry 1 Clay Shaundra · CIK 0001857606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,227 Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:50 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,456 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029720 · doc4.xml · nonDerivative · entry 2 Clay Shaundra · CIK 0001857606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,741 Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:50 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029720 · doc4.xml · nonDerivative · entry 1 Clay Shaundra · CIK 0001857606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,285 Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033135 · doc4.xml · nonDerivative · entry 3 Clay Shaundra · CIK 0001857606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,020 Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033135 · doc4.xml · nonDerivative · entry 2 Clay Shaundra · CIK 0001857606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124 Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 64 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033135 · doc4.xml · nonDerivative · entry 1 Clay Shaundra · CIK 0001857606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.